MDT logo

Medtronic (MDT) EBITDA

annual EBITDA:

$8.20B-$494.00M(-5.68%)
April 30, 2024

Summary

  • As of today (April 14, 2025), MDT annual EBITDA is $8.20 billion, with the most recent change of -$494.00 million (-5.68%) on April 30, 2024.
  • During the last 3 years, MDT annual EBITDA has risen by +$681.00 million (+9.05%).
  • MDT annual EBITDA is now -13.33% below its all-time high of $9.46 billion, reached on April 27, 2018.

Performance

MDT EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDTincome statement metrics

quarterly EBITDA:

$2.40B-$40.00M(-1.64%)
January 24, 2025

Summary

  • As of today (April 14, 2025), MDT quarterly EBITDA is $2.40 billion, with the most recent change of -$40.00 million (-1.64%) on January 24, 2025.
  • Over the past year, MDT quarterly EBITDA has stayed the same.
  • MDT quarterly EBITDA is now -11.20% below its all-time high of $2.71 billion, reached on April 27, 2018.

Performance

MDT quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDTincome statement metrics

TTM EBITDA:

$8.65B+$94.00M(+1.10%)
January 24, 2025

Summary

  • As of today (April 14, 2025), MDT TTM EBITDA is $8.65 billion, with the most recent change of +$94.00 million (+1.10%) on January 24, 2025.
  • Over the past year, MDT TTM EBITDA has stayed the same.
  • MDT TTM EBITDA is now -8.47% below its all-time high of $9.46 billion, reached on July 26, 2019.

Performance

MDT TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDTincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

MDT EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-5.7%0.0%0.0%
3 y3 years+9.1%0.0%0.0%
5 y5 years-11.8%0.0%0.0%

MDT EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-6.5%+9.1%-1.6%+40.4%-4.0%+5.5%
5 y5-year-11.8%+9.1%-1.6%+131.3%-8.4%+40.3%
alltimeall time-13.3%>+9999.0%-11.2%+680.3%-8.5%+6290.3%

Medtronic EBITDA History

DateAnnualQuarterlyTTM
Jan 2025
-
$2.40B(-1.6%)
$8.65B(+1.1%)
Oct 2024
-
$2.44B(+16.5%)
$8.56B(+3.4%)
Jul 2024
-
$2.10B(+22.6%)
$8.28B(+1.0%)
Apr 2024
$8.20B(-5.7%)
$1.71B(-25.9%)
$8.20B(-7.9%)
Jan 2024
-
$2.31B(+6.7%)
$8.91B(+1.0%)
Oct 2023
-
$2.17B(+7.4%)
$8.82B(-0.2%)
Jul 2023
-
$2.02B(-16.6%)
$8.84B(+1.6%)
Apr 2023
-
$2.42B(+8.8%)
$8.70B(-0.2%)
Apr 2023
$8.70B(-0.9%)
-
-
Jan 2023
-
$2.22B(+1.7%)
$8.71B(-2.0%)
Oct 2022
-
$2.18B(+16.4%)
$8.89B(-1.3%)
Jul 2022
-
$1.88B(-22.9%)
$9.01B(+2.7%)
Apr 2022
$8.78B(+16.7%)
$2.43B(+1.5%)
$8.78B(+0.5%)
Jan 2022
-
$2.40B(+4.0%)
$8.74B(+4.3%)
Oct 2021
-
$2.31B(+40.5%)
$8.38B(+8.3%)
Jul 2021
-
$1.64B(-31.4%)
$7.74B(+2.9%)
Apr 2021
$7.52B(-3.7%)
$2.39B(+17.2%)
$7.52B(+21.9%)
Jan 2021
-
$2.04B(+22.5%)
$6.17B(-5.5%)
Oct 2020
-
$1.67B(+17.0%)
$6.53B(-6.6%)
Jul 2020
-
$1.42B(+37.1%)
$6.99B(-10.5%)
Apr 2020
$7.81B(-16.0%)
$1.04B(-56.7%)
$7.81B(-17.3%)
Jan 2020
-
$2.40B(+12.6%)
$9.45B(+1.2%)
Oct 2019
-
$2.13B(-5.0%)
$9.34B(-1.2%)
Jul 2019
-
$2.24B(-16.2%)
$9.46B(+1.7%)
Apr 2019
$9.30B(-1.7%)
$2.68B(+17.0%)
$9.30B(-0.3%)
Jan 2019
-
$2.29B(+1.8%)
$9.33B(+3.6%)
Oct 2018
-
$2.25B(+7.6%)
$9.00B(+4.2%)
Jul 2018
-
$2.09B(-22.8%)
$8.64B(+0.7%)
Apr 2018
$9.46B(+9.9%)
$2.71B(+37.9%)
$8.58B(+3.2%)
Jan 2018
-
$1.96B(+4.2%)
$8.31B(-0.0%)
Oct 2017
-
$1.88B(-7.1%)
$8.32B(-3.8%)
Jul 2017
-
$2.03B(-17.1%)
$8.64B(+0.3%)
Apr 2017
$8.61B(+0.8%)
$2.44B(+24.3%)
$8.61B(+1.4%)
Jan 2017
-
$1.97B(-11.0%)
$8.49B(-2.3%)
Oct 2016
-
$2.21B(+10.6%)
$8.70B(+1.2%)
Jul 2016
-
$2.00B(-14.0%)
$8.59B(+0.6%)
Apr 2016
$8.54B(+56.5%)
$2.32B(+7.1%)
$8.54B(+15.7%)
Jan 2016
-
$2.17B(+3.1%)
$7.38B(+8.7%)
Oct 2015
-
$2.10B(+8.0%)
$6.79B(+13.0%)
Jul 2015
-
$1.95B(+67.6%)
$6.01B(+10.1%)
Apr 2015
$5.46B(+10.6%)
$1.16B(-26.3%)
$5.46B(+7.1%)
Jan 2015
-
$1.58B(+19.0%)
$5.09B(+6.6%)
Oct 2014
-
$1.32B(-5.1%)
$4.78B(-2.0%)
Jul 2014
-
$1.40B(+74.6%)
$4.88B(-1.1%)
Apr 2014
$4.93B(-9.6%)
$799.00M(-36.6%)
$4.93B(-12.0%)
Jan 2014
-
$1.26B(-11.4%)
$5.61B(-3.5%)
Oct 2013
-
$1.42B(-1.9%)
$5.81B(+5.0%)
Jul 2013
-
$1.45B(-1.2%)
$5.54B(+1.4%)
Apr 2013
$5.46B(+2.5%)
$1.47B(+0.1%)
$5.46B(+2.6%)
Jan 2013
-
$1.47B(+27.8%)
$5.32B(+2.2%)
Oct 2012
-
$1.15B(-16.4%)
$5.20B(-3.6%)
Jul 2012
-
$1.37B(+3.4%)
$5.39B(+1.3%)
Apr 2012
$5.33B(+8.3%)
$1.33B(-1.6%)
$5.33B(+1.9%)
Jan 2012
-
$1.35B(+0.7%)
$5.23B(+1.0%)
Oct 2011
-
$1.34B(+2.7%)
$5.17B(+5.3%)
Jul 2011
-
$1.31B(+6.3%)
$4.91B(-0.6%)
Apr 2011
$4.92B(-3.9%)
$1.23B(-5.4%)
$4.94B(-5.6%)
Jan 2011
-
$1.30B(+20.3%)
$5.24B(-1.0%)
Oct 2010
-
$1.08B(-19.0%)
$5.29B(-5.5%)
Jul 2010
-
$1.33B(-12.4%)
$5.60B(+9.4%)
Apr 2010
$5.12B(+45.8%)
$1.52B(+12.5%)
$5.12B(+32.2%)
Jan 2010
-
$1.35B(-2.4%)
$3.87B(+5.4%)
Oct 2009
-
$1.39B(+62.6%)
$3.67B(+15.6%)
Jul 2009
-
$853.00M(+207.9%)
$3.18B(-9.5%)
Apr 2009
$3.51B(-7.1%)
$277.00M(-76.0%)
$3.51B(-6.1%)
Jan 2009
-
$1.15B(+29.4%)
$3.74B(-0.7%)
Oct 2008
-
$892.00M(-24.9%)
$3.76B(-2.9%)
Jul 2008
-
$1.19B(+135.5%)
$3.88B(+2.6%)
Apr 2008
$3.78B(-12.6%)
$504.00M(-57.3%)
$3.78B(-14.8%)
Jan 2008
-
$1.18B(+17.3%)
$4.43B(+2.3%)
Oct 2007
-
$1.01B(-7.5%)
$4.33B(-1.3%)
Jul 2007
-
$1.09B(-6.2%)
$4.39B(+1.5%)
Apr 2007
$4.32B(+1.7%)
$1.16B(+7.4%)
$4.32B(-0.2%)
Jan 2007
-
$1.08B(+1.8%)
$4.33B(+1.2%)
Oct 2006
-
$1.06B(+3.8%)
$4.28B(+0.7%)
Jul 2006
-
$1.02B(-12.6%)
$4.25B(+0.1%)
Apr 2006
$4.25B(+8.8%)
$1.17B(+13.7%)
$4.25B(+1.9%)
Jan 2006
-
$1.03B(-0.5%)
$4.17B(+1.0%)
Oct 2005
-
$1.03B(+1.4%)
$4.13B(+2.7%)
Jul 2005
-
$1.02B(-6.6%)
$4.02B(+2.9%)
Apr 2005
$3.91B
$1.09B(+10.7%)
$3.91B(+0.8%)
Jan 2005
-
$985.50M(+6.7%)
$3.88B(+2.7%)
Oct 2004
-
$923.90M(+1.9%)
$3.78B(+3.5%)
DateAnnualQuarterlyTTM
Jul 2004
-
$906.50M(-14.6%)
$3.65B(+2.8%)
Apr 2004
$3.62B(+18.4%)
$1.06B(+20.0%)
$3.55B(+5.7%)
Jan 2004
-
$884.80M(+11.0%)
$3.36B(+3.6%)
Oct 2003
-
$796.80M(-1.4%)
$3.24B(+1.8%)
Jul 2003
-
$808.10M(-7.2%)
$3.19B(+4.1%)
Apr 2003
$3.06B(+23.5%)
$871.00M(+13.4%)
$3.06B(+4.8%)
Jan 2003
-
$767.80M(+3.6%)
$2.92B(+5.6%)
Oct 2002
-
$740.80M(+8.6%)
$2.77B(+5.9%)
Jul 2002
-
$682.10M(-6.7%)
$2.61B(+5.4%)
Apr 2002
$2.48B(+13.9%)
$731.40M(+19.4%)
$2.48B(+5.8%)
Jan 2002
-
$612.50M(+4.3%)
$2.34B(+3.2%)
Oct 2001
-
$587.40M(+7.3%)
$2.27B(+3.4%)
Jul 2001
-
$547.50M(-8.0%)
$2.20B(+0.9%)
Apr 2001
$2.18B(+12.9%)
$594.90M(+10.1%)
$2.18B(+0.8%)
Jan 2001
-
$540.50M(+5.3%)
$2.16B(+3.5%)
Oct 2000
-
$513.50M(-2.6%)
$2.08B(+1.9%)
Jul 2000
-
$527.00M(-8.6%)
$2.05B(+5.8%)
Apr 2000
$1.93B(+22.0%)
$576.60M(+23.6%)
$1.93B(+8.5%)
Jan 2000
-
$466.60M(-1.9%)
$1.78B(+5.1%)
Oct 1999
-
$475.50M(+14.6%)
$1.70B(+6.5%)
Jul 1999
-
$415.10M(-2.5%)
$1.59B(+1.3%)
Apr 1999
$1.58B(+25.5%)
$425.60M(+11.9%)
$1.57B(+1.5%)
Jan 1999
-
$380.20M(+2.3%)
$1.55B(+6.3%)
Oct 1998
-
$371.70M(-5.9%)
$1.46B(+9.1%)
Jul 1998
-
$395.10M(-1.9%)
$1.34B(+11.8%)
Apr 1998
$1.26B(+20.4%)
$402.80M(+39.7%)
$1.20B(+1.9%)
Jan 1998
-
$288.30M(+15.4%)
$1.17B(+6.5%)
Oct 1997
-
$249.90M(-1.8%)
$1.10B(+2.7%)
Jul 1997
-
$254.50M(-33.2%)
$1.07B(+2.7%)
Apr 1997
$1.05B(+39.7%)
$380.80M(+76.0%)
$1.05B(+21.8%)
Jan 1997
-
$216.40M(-2.3%)
$858.50M(+3.4%)
Oct 1996
-
$221.40M(-2.3%)
$830.00M(+4.7%)
Jul 1996
-
$226.70M(+16.9%)
$792.50M(+5.7%)
Apr 1996
$748.00M(+37.8%)
$194.00M(+3.2%)
$749.70M(+5.1%)
Jan 1996
-
$187.90M(+2.2%)
$713.10M(+8.8%)
Oct 1995
-
$183.90M(0.0%)
$655.20M(+9.5%)
Jul 1995
-
$183.90M(+16.8%)
$598.10M(+10.2%)
Apr 1995
$542.80M(+32.0%)
$157.40M(+21.1%)
$542.70M(+7.6%)
Jan 1995
-
$130.00M(+2.5%)
$504.20M(+5.6%)
Oct 1994
-
$126.80M(-1.3%)
$477.50M(+4.5%)
Jul 1994
-
$128.50M(+8.1%)
$457.00M(+11.1%)
Apr 1994
$411.20M(+12.8%)
$118.90M(+15.1%)
$411.30M(+3.5%)
Jan 1994
-
$103.30M(-2.8%)
$397.30M(+4.3%)
Oct 1993
-
$106.30M(+28.4%)
$380.90M(+5.7%)
Jul 1993
-
$82.80M(-21.1%)
$360.40M(-1.4%)
Apr 1993
$364.70M(+19.4%)
$104.90M(+20.7%)
$365.40M(+1.5%)
Jan 1993
-
$86.90M(+1.3%)
$360.00M(+5.1%)
Oct 1992
-
$85.80M(-2.3%)
$342.60M(+4.4%)
Jul 1992
-
$87.80M(-11.8%)
$328.10M(+7.4%)
Apr 1992
$305.40M(+20.8%)
$99.50M(+43.2%)
$305.40M(+8.9%)
Jan 1992
-
$69.50M(-2.5%)
$280.40M(+3.0%)
Oct 1991
-
$71.30M(+9.5%)
$272.20M(+5.5%)
Jul 1991
-
$65.10M(-12.6%)
$258.00M(+4.5%)
Apr 1991
$252.90M(+23.7%)
$74.50M(+21.5%)
$247.00M(+8.8%)
Jan 1991
-
$61.30M(+7.4%)
$227.00M(+4.3%)
Oct 1990
-
$57.10M(+5.5%)
$217.60M(+3.6%)
Jul 1990
-
$54.10M(-0.7%)
$210.10M(-39.6%)
Apr 1990
$204.40M(+17.3%)
$54.50M(+5.0%)
$347.90M(-388.2%)
Jan 1990
-
$51.90M(+4.6%)
-$120.70M(-950.0%)
Oct 1989
-
$49.60M(-74.2%)
$14.20M(-90.3%)
Jul 1989
-
$191.90M(-146.3%)
$145.80M(+12.4%)
Apr 1989
$174.30M(+9.6%)
-$414.10M(-321.7%)
$129.70M(-38.2%)
Jan 1989
-
$186.80M(+3.1%)
$209.80M(+10.2%)
Oct 1988
-
$181.20M(+3.1%)
$190.30M(+18.0%)
Jul 1988
-
$175.80M(-152.6%)
$161.30M(+24.0%)
Apr 1988
$159.10M(+20.4%)
-$334.00M(-299.6%)
$130.10M(-38.5%)
Jan 1988
-
$167.30M(+9.9%)
$211.70M(+27.4%)
Oct 1987
-
$152.20M(+5.3%)
$166.20M(+23.9%)
Jul 1987
-
$144.60M(-157.3%)
$134.10M(+26.9%)
Apr 1987
$132.10M(+32.6%)
-$252.40M(-307.2%)
$105.70M(-25.9%)
Jan 1987
-
$121.80M(+1.4%)
$142.70M(+17.9%)
Oct 1986
-
$120.10M(+3.4%)
$121.00M(+19.1%)
Jul 1986
-
$116.20M(-153.9%)
$101.60M(+21.8%)
Apr 1986
$99.60M(+55.4%)
-$215.40M(-315.2%)
$83.40M(+95.3%)
Jan 1986
-
$100.10M(-0.6%)
$42.70M(+12.4%)
Oct 1985
-
$100.70M(+2.8%)
$38.00M(+4.7%)
Jul 1985
-
$98.00M(-138.3%)
$36.30M(-5.7%)
Apr 1985
$64.10M(-29.6%)
-$256.10M(-368.4%)
$38.50M(-25.5%)
Jan 1985
-
$95.40M(-3.6%)
$51.70M(-13.0%)
Oct 1984
-
$99.00M(-1.2%)
$59.40M(-250.0%)
Jul 1984
-
$100.20M(-141.3%)
-$39.60M(-71.7%)
Apr 1984
$91.10M
-$242.90M(-335.6%)
-$139.80M(-235.6%)
Jan 1984
-
$103.10M
$103.10M

FAQ

  • What is Medtronic annual EBITDA?
  • What is the all time high annual EBITDA for Medtronic?
  • What is Medtronic annual EBITDA year-on-year change?
  • What is Medtronic quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Medtronic?
  • What is Medtronic quarterly EBITDA year-on-year change?
  • What is Medtronic TTM EBITDA?
  • What is the all time high TTM EBITDA for Medtronic?
  • What is Medtronic TTM EBITDA year-on-year change?

What is Medtronic annual EBITDA?

The current annual EBITDA of MDT is $8.20B

What is the all time high annual EBITDA for Medtronic?

Medtronic all-time high annual EBITDA is $9.46B

What is Medtronic annual EBITDA year-on-year change?

Over the past year, MDT annual EBITDA has changed by -$494.00M (-5.68%)

What is Medtronic quarterly EBITDA?

The current quarterly EBITDA of MDT is $2.40B

What is the all time high quarterly EBITDA for Medtronic?

Medtronic all-time high quarterly EBITDA is $2.71B

What is Medtronic quarterly EBITDA year-on-year change?

Over the past year, MDT quarterly EBITDA has changed by $0.00 (0.00%)

What is Medtronic TTM EBITDA?

The current TTM EBITDA of MDT is $8.65B

What is the all time high TTM EBITDA for Medtronic?

Medtronic all-time high TTM EBITDA is $9.46B

What is Medtronic TTM EBITDA year-on-year change?

Over the past year, MDT TTM EBITDA has changed by $0.00 (0.00%)
On this page